Remdesivir
Antiviral drug
Remdesivir ▸ Facts ▸ Comments ▸ News ▸ Videos
Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID‑19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in numerous countries.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Remdesivir slows down heartbeat: StudyIndiaTimes - Published | |
India's Remdesivir production capacity increased to 122.49 lakh vials per month in June: GovernmentShortages of Remdesivir injections in the market were noticed in April and May 2021 due to a sudden surge in the demand for the drug for managing Covid-19 patients, Union health minister Mansukh..IndiaTimes - Published |
| Search this site and the web: |
